ICTS is a clinical trials support company that specializes in achieving superior results in research studies by building and maintaining stronger connections throughout the entire clinical trial process. Our innovative and customized communication models provide the foundation for higher quality data and results.
Virtual knowledge network NIMHANS Echo : Innovative tele- mentoring model for skilled capacity building in addiction & mental health by Prabhat Chand , NIMHANS, India
A system based on continual learning: a guide to using measurement for improvement - Phil Duncan, Patient Safety Collaborative Lead, NHS Improving Quality and Ian Chappell, Improvement Manager, NHS Improving Quality
Presentation from the Patient Safety Collaborative launch event held in London on 14 October 2014
More information at http://www.nhsiq.nhs.uk/improvement-programmes/patient-safety/patient-safety-collaboratives.aspx
ICTS is a clinical trials support company that specializes in achieving superior results in research studies by building and maintaining stronger connections throughout the entire clinical trial process. Our innovative and customized communication models provide the foundation for higher quality data and results.
Virtual knowledge network NIMHANS Echo : Innovative tele- mentoring model for skilled capacity building in addiction & mental health by Prabhat Chand , NIMHANS, India
A system based on continual learning: a guide to using measurement for improvement - Phil Duncan, Patient Safety Collaborative Lead, NHS Improving Quality and Ian Chappell, Improvement Manager, NHS Improving Quality
Presentation from the Patient Safety Collaborative launch event held in London on 14 October 2014
More information at http://www.nhsiq.nhs.uk/improvement-programmes/patient-safety/patient-safety-collaboratives.aspx
Implementation of Online Safety Incident Reporting System in a Tertiary Care Teaching Hospital by Dr. Bijoy Johnson, Dept. of Hospital Administration, KMC Manipal, India
Dr David Raw - The Emergency Laparotomy CollaborativeInnovation Agency
Presentation by Dr David Raw, Deputy Divisional Medical Director, Aintree University Hospitals NHS Foundation Trust at the Emergency Laparotomy Collaborative, 13 November 2018 at Bolton Whites Hotel.
Ramani Moonesinghe, Associate National Clinical Director for Elective Care at NHS England, discusses the use of data for monitoring care quality at various levels within the system.
Monitoring quality of care: making the most of dataNuffield Trust
Chris Sherlaw-Johnson, Senior Research Analyst at the Nuffield Trust, introduced the Monitoring quality of care conference and gives an overview of some of the approaches that we've been using at the Trust to identify where care quality has been improving, especially for frail and older people.
Before we change actions or activities within the healthcare, the first point is to understand how staff and consumers think about the system we are in now.
Implementation of Online Safety Incident Reporting System in a Tertiary Care Teaching Hospital by Dr. Bijoy Johnson, Dept. of Hospital Administration, KMC Manipal, India
Dr David Raw - The Emergency Laparotomy CollaborativeInnovation Agency
Presentation by Dr David Raw, Deputy Divisional Medical Director, Aintree University Hospitals NHS Foundation Trust at the Emergency Laparotomy Collaborative, 13 November 2018 at Bolton Whites Hotel.
Ramani Moonesinghe, Associate National Clinical Director for Elective Care at NHS England, discusses the use of data for monitoring care quality at various levels within the system.
Monitoring quality of care: making the most of dataNuffield Trust
Chris Sherlaw-Johnson, Senior Research Analyst at the Nuffield Trust, introduced the Monitoring quality of care conference and gives an overview of some of the approaches that we've been using at the Trust to identify where care quality has been improving, especially for frail and older people.
Before we change actions or activities within the healthcare, the first point is to understand how staff and consumers think about the system we are in now.
Comunicação - partilha de práticas da BE do Agrupamento de Escolas rainha St Isabel.
TEMA: Ler, Escrever e Aprender na Era Digital... Ampliar e Colaborar!
European Decision Support Days 2015 agendaCopperberg
The market of BI is shifting from early adoption to actual implementation.
It has gradually evolved from being rigid to a much more
flexible, agile process, that is cloud enabled, that organizations
as well as individuals can utilize. This change has now reached Europe,
with 37% of the companies performing Business Intelligence projects.
Big Data is projected to be a $28.5 billion market in 2014, growing to
$50.1 billion in 2015. The average business expects to spend about $8
million on Big Data related activities.
The early adopters of Business Intelligence and Big Data have
gained a significant advantage. Bain & Company examined over
400 large companies and their research has shown that those
with the most advanced analytics capabilities are outperforming
their competitors by wide margins. Leaders in the field are twice as
likely to be in the top quartile of financial performance within their
industries, five times as likely to make decisions much faster than
market peers and are three times as likely to execute decisions as
intended.
Advanced users of BI are now shifting from desktop to mobile, but
the question is how to manage this shift and overcome issues to
enable mobile decision support for decision making anytime, anywhere.
Converging the cloud and BI to enable the central coordination of
applications for information delivery to any device asks for a complete
tool that meets quality standards. Up till today, a complete tool
does not exist and it is very challenging to show the value of BI to
convince management and support decisions. This lack of value
measurements results in difficulties of ROI measurements of BI
solutions and thus the demand for performance management is
growing momentum.
After the staggering success and interest for our local Business Intelligence
conferences in Stockholm, Oslo and Amsterdam, we are
now glad to present our inaugural Pan-European Decision Support
Days conference. The Decision Support Days is not just a conference.
It is a business focused benchmarking tool for strategy makers and
business owners working with Business Intelligence and Business
Analytics from across Europe and beyond. The conference will shed
light on the current BI or BA strategies, processes, tools and models
that organisations in Europe and beyond are using in order to utilize
both internal and external data to drive business and enable faster
data-driven decision making.
Welcome to the European Decision Support Days 2015
Find out more: http://www.decisionsupportdays.com/
A few slides on Social Business and ROI, some use case examples, and finally a kick in the _ _ _ for Leaders to start experimenting, if they truly would like to understand ROI.
Presented at Grundfos, Bjerringbro, Denmark, on March 26th, 2013.
Please reach out to me if any questions, comments, etc. at https://twitter.com/chris_carlsson
Atrapamiento de Morton. Tratamiento artroscópico. Morton’s Neuroma. Seminario en Español, durante la residencia en el Hospital Universitario de Caracas, Universidad Central de Venezuela.
Don Berwick’s ‘Triple Aims of Healthcare’ emphasises the pursuit of improved patient experience as top priority for healthcare systems. However, leaders are challenged with having a clear ‘process’ for improving patient experience. Data collection is often fragmented, person-dependent, inconsistently applied and not reported in real-time. Results take 3 to 18 months before being communicated back to the wards, resulting in a lack of accountability, transparency and meaningful change.
Results obtained in the NSW Bureau of Health Information surveys led Western Sydney Local Health District to improve its strategy around measurement of patient experience. Facilitating the collection of timely and granular feedback was needed. Implementation of a new patient survey system (MES Experience) in August 2016 provided a combination of real-time data collection and the unique 6E Framework (experience, emotions, engagement, execution, excellence and evolution) which is now guiding and driving quality improvements and meaningful change for consumers.
Ronan Herlihy on Engaging Clinicians with data on their ordering practicesCirdan
The appropriate ordering project uses data extracted from Electronic Medical Record to create dashboards to inform and engage clinicians in ordering practices. This presentation looks at the techniques used to create answers for the clinicians questions and discusses the purpose behind 12 dashboards. It looks at the change management approaches and challenges.
The initial pilot project has been embraced by a number of local health districts in NSW and templates have been made available along with training tools.
Patient Blood Management: Impact of Quality Data on Patient OutcomesViewics
Patient blood management (PBM) has been proven to improve patient outcomes and save hospitals millions of dollars. Ensuring the quality of your data is central to decision making and critical to having a strong PBM program.
Would you like to learn how your organization can improve patient outcomes by implementing a PBM program based on accurate data?
If so, view this presentation by blood management expert Lance Trewhella. Lance presents how to develop a successful, evidence-based, multidisciplinary PBM program aimed at optimizing the care of patients who might need transfusion.
You’ll learn:
• Current recommendations for blood transfusion utilization
• The impact of quality data on PBM programs
• Best data practices in PBM
Delivering Quality Through eHealth and Information TechnologyNHSScotlandEvent
Using information to improve the quality of care is becoming increasingly important. This session will highlight how the new eHealth Strategy links to the quality agenda and the benefits and successes of three innovative eHealth tools.
This PPT explains about how Singapore is using IT in healthcare, Integrated Health Information Systems, Singapore's Shifting Demographics and 2020 Master Plan. For more information visit: http://www.transformhealth-it.org/
At the RACMA Conference Talked about how to use machine learning to improve patient feedback as well as building the rules engine to advise on patient experience improvement. Here are some of the slides and stories shared at the conference which seem to be received very well.
Patient Experience Roundtable Sydney 2018 Leading Change & Transformation in ...Dr Avnesh Ratnanesan (Avi)
Energesse and The Beryl Institute's Patient Experience Roundtable brought together executive senior patient experience champions from around Australia to brainstorm and collaborate on the most important issues affecting organisations in patient experience.
"When our Patient Experience measures improved, so did our Quality and Safety measures" - Sir Robert Naylor, CEO, University College London Hospitals NHS Trust, Sustainable Health Transformation 2014
A presentation on Malaysian Cancer Care Initiative 2017 hosted by Ramsay Sime Darby Asia. With an increased focus on involving patients to improve safety and quality as well as implementing sustainable cost-effective improvements, person-centred care is key.
A step by step guide on how to holistically improve patient experience, adaptable for any healthcare setting. This training is presented by Dr Avnesh Ratnanesan, who is a thought-leader and expert on practical methods for improving patient experience and consumer engagement in the health setting.
Dr Avi Ratnanesan is the Chief Executive Officer of Energesse, a leading firm that specialises in improving patient experience and customer experience in healthcare. Energesse provides thought leadership in patient-centred innovation and technology solutions including MES Experience for real-time patient feedback and PanSensic for free-text analytics of patient stories.
Dr Avi Ratnanesan is the Chief Executive Officer of Energesse, a leading firm that specialises in improving patient experience and customer experience in healthcare. Energesse provides thought leadership in patient-centred innovation and technology solutions including MES Experience for real-time patient feedback and PanSensic for free-text analytics of patient stories.
Energesse and Palladium Executive Breakfast Series.
The healthcare ecosystem is becoming increasingly complex and consumer/patient needs and expectations are escalating. The drive to create a more sustainable healthcare system means that industry players are forced to deliver new models of care whilst developing more sustainable business models under ever more stringent budgetary conditions. As cost cutting and reengineering efforts reach diminishing returns, it has become obvious that the solution to this complex set of issues is to reframe the problem, working backwards from patients and health consumers to build models that deliver compelling experiences to consumers/patients and superior societal health outcomes.
This presentation will focus on how outcomes and major issues in the National Health Services (NHS UK) are measured using patient and staff experiences. It will also describe how latest technologies are being utilized to measure success in these areas.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Translating Patient Experience into Health System Improvement
1. 1
Dr Avnesh Ratnanesan (Avi)
CEO, Energesse
Leading Insights in Healthcare and Wellness
‘Translating Patient Experience into Health System
Improvement’
UK Case Studies and the ‘MES Experience’ digital platform
1
2. Executive Summary
Introduction to PX
The Technology platform – ‘MES Experience’
UK Implementation Case Studies
Learning Outcomes for Australia
Conclusion
3. Introduction to Patient Experience (PX)
Australian hospitals now accredited on PX
UK NHS precedes changes by 3-5 years due to Mid-Staffordshire crisis
£11mil investigation - disconnect between management, front line staff &
patients
In Australia, managers uncertain of importance and best practices to collect,
analyse, measure and improve PX
Innovative solutions enable ‘early warning systems’ and patient-centred
improvements
*PHIAC, Operations of PHI Annual Report 2013-14
4. MES Experience – Digital Survey & Analytics platform
✓ Survey design tool – build your own surveys, unlimited volume
✓ Survey library – one place to manage all surveys
✓ Real time Reports from Board to Ward – ‘pain points’ from patient perspective
5. MES Experience – Multichannel Data Collection
Online
Text Message
(SMS)
Email
Kiosk and Tablet
Automated Telephone
Surveys
Postcards and Drop-boxes
6. Actionable insights from comments:
• Patient Emotions & Views of staff attitudes
• Staff compassion & Communications
Automated Text Analysis
Measure Compassion & Staff Attitudes
7. Implementation - NHS Case Studies
1. Leeds NHS Trust and Bradford Teaching Hospital NHS Trust
1. Standard PX metrics incorporated in surveys
1. Increase patient response rates by 15%
1. Multi-lingual approach utilised – Urdu, Slovak, Punjab, Czech
1. Online and paper based survey results combined
8. *Sample analysis with PanSensic Emotional Lens
% Patient Emotional Response Compassion Trend Staff Attitude Trend
Feedback translated into Management Priorities
Monitor trend data across ward, department & hospital levels critical
Resolve issues with ‘Plan - Do – Study – Act’ approach
9. Learning Outcomes for Australian hospitals
1. Methodology for collecting experiences and question format is
critical i.e. open ended vs. close ended questions
1. Analyse data into actionable insights for management
1. Transparently highlight feedback and improvements to drive
culture change
1. Accountable internal champion to ensure solutions are aligned
with outcomes.
1. Alleviation of concerns = ‘early warning system’ to reduce
systemic quality & safety errors and potential lawsuits
10. Conclusions
1. Translating PX into actionable insights = grey, rapidly evolving field
1. Have a systematic strategy and ‘data-driven/evidence-based’ process for PX
1. Automated surveys and ‘big data’ technologies (e.g. MES Experience) are faster,
more objective and cost-effective insights
1. Implement service improvements through a prioritisation process involving a
multi-disciplinary team
11. To Receive a Free Copy…
SMS 0438 614 233
(Full Name & E-mail)
avnesh@energesse.com
12. The ONE CHANGE to drive Sustainable, Patient-Centred Healthcare
AREA TO FOCUS
Cumulative Costs
(Headcount, Time, $$$)
Organisation’s
cycle
Cost Savings
70-80%20-30%
Gather
Research
Implement Projects
Analyse
Insights
Determine
Strategies